Department of Diagnostic Ultrasound, Tongde Hospital of Zhejiang Province, Hangzhou, 310012, P. R. China.
Shanghai Institute of Ultrasound in Medicine, Shanghai Jiaotong University Affiliated, Shanghai Sixth People's Hospital, Shanghai, 200233, P. R. China.
Adv Mater. 2017 Mar;29(10). doi: 10.1002/adma.201604105. Epub 2016 Dec 19.
As a special cross-disciplinary research frontier, nanoultrasonic biomedicine refers to the design and synthesis of nanomaterials to solve some critical issues of ultrasound (US)-based biomedicine. The concept of nanoultrasonic biomedicine can also overcome the drawbacks of traditional microbubbles and promote the generation of novel US-based contrast agents or synergistic agents for US theranostics. Here, we discuss the recent developments of material chemistry in advancing the nanoultrasonic biomedicine for diverse US-based bio-applications. We initially introduce the design principles of novel nanoplatforms for serving the nanoultrasonic biomedicine, from the viewpoint of synthetic material chemistry. Based on these principles and diverse US-based bio-application backgrounds, the representative proof-of-concept paradigms on this topic are clarified in detail, including nanodroplet vaporization for intelligent/responsive US imaging, multifunctional nano-contrast agents for US-based multi-modality imaging, activatable synergistic agents for US-based therapy, US-triggered on-demand drug releasing, US-enhanced gene transfection, US-based synergistic therapy on combating the cancer and potential toxicity issue of screening various nanosystems suitable for nanoultrasonic biomedicine. It is highly expected that this novel nanoultrasonic biomedicine and corresponding high performance in US imaging and therapy can significantly promote the generation of new sub-discipline of US-based biomedicine by rationally integrating material chemistry and theranostic nanomedicine with clinical US-based biomedicine.
作为一个特殊的跨学科研究前沿,纳声生物医学是指设计和合成纳米材料,以解决基于超声(US)的生物医学中的一些关键问题。纳声生物医学的概念也可以克服传统微泡的缺点,并促进新型基于 US 的对比剂或协同剂的产生,用于 US 治疗诊断学。在这里,我们讨论了材料化学在推进各种基于 US 的生物应用的纳声生物医学方面的最新进展。我们首先从合成材料化学的角度介绍了新型纳米平台用于纳声生物医学的设计原则。基于这些原则和各种基于 US 的生物应用背景,详细阐明了这个主题的代表性概念验证范例,包括用于智能/响应性 US 成像的纳米液滴汽化、用于基于 US 的多模态成像的多功能纳米对比剂、用于基于 US 的治疗的可激活协同剂、基于 US 的按需药物释放、US 增强的基因转染、基于 US 的协同治疗以对抗癌症和筛选适合纳声生物医学的各种纳米系统的潜在毒性问题。人们高度期望这种新型纳声生物医学及其在 US 成像和治疗方面的高性能,通过合理地将材料化学和治疗纳米医学与基于 US 的临床生物医学相结合,能够显著促进基于 US 的生物医学的新子学科的产生。